Carsten Rudolph

Planegg, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

mRNA therapy improves the composition and motility in CCDC40-deficient cilia in vitro and in vivo.

mRNA therapy improves the composition and motility in CCDC40-deficient cilia in vitro and in vivo.

Journal: American journal of respiratory cell and molecular biology

Published: July 30, 2025

mRNA therapy improves the composition and motility in CCDC40-deficient cilia in vitro and in vivo.

mRNA therapy improves the composition and motility in CCDC40-deficient cilia in vitro and in vivo.

Journal: American journal of respiratory cell and molecular biology

Published: July 30, 2025

Correction: Alternative oxidase encoded by sequence-optimized and chemically-modified RNA transfected into mammalian cells is catalytically active.

Correction: Alternative oxidase encoded by sequence-optimized and chemically-modified RNA transfected into mammalian cells is catalytically active.

Journal: Gene therapy

Published: August 15, 2024

Transcriptional Dynamics of NRF2 Overexpression and KEAP1-NRF2 Inhibitors in Human Cell Line and Primary Lung Cells.

Transcriptional Dynamics of NRF2 Overexpression and KEAP1-NRF2 Inhibitors in Human Cell Line and Primary Lung Cells.

Journal: Antioxidants (Basel, Switzerland)

Published: June 20, 2024

Mucosal IFNλ1 mRNA-based immunomodulation effectively reduces SARS-CoV-2 induced mortality in mice.

Mucosal IFNλ1 mRNA-based immunomodulation effectively reduces SARS-CoV-2 induced mortality in mice.

Journal: EMBO reports

Published: January 16, 2024

Dynamic mRNA polyplexes benefit from bioreducible cleavage sites for in vitro and in vivo transfer.

Dynamic mRNA polyplexes benefit from bioreducible cleavage sites for in vitro and in vivo transfer.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: May 18, 2021

Alternative oxidase encoded by sequence-optimized and chemically-modified RNA transfected into mammalian cells is catalytically active.

Alternative oxidase encoded by sequence-optimized and chemically-modified RNA transfected into mammalian cells is catalytically active.

Journal: Gene therapy

Published: November 07, 2020

Preclinical Evaluation of a Novel TALEN Targeting CCR5 Confirms Efficacy and Safety in Conferring Resistance to HIV-1 Infection.

Preclinical Evaluation of a Novel TALEN Targeting CCR5 Confirms Efficacy and Safety in Conferring Resistance to HIV-1 Infection.

Journal: Biotechnology journal

Published: May 18, 2020

Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases.

Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: November 21, 2018

Segmented poly(A) tails significantly reduce recombination of plasmid DNA without affecting mRNA translation efficiency or half-life.

Segmented poly(A) tails significantly reduce recombination of plasmid DNA without affecting mRNA translation efficiency or half-life.

Journal: RNA (New York, N.Y.)

Published: October 18, 2018

Conversion of adult human fibroblasts into neural precursor cells using chemically modified mRNA.

Conversion of adult human fibroblasts into neural precursor cells using chemically modified mRNA.

Journal: Heliyon

Published: June 11, 2018

Chemically Modified Messenger RNA: Modified RNA Application for Treatment of Achilles Tendon Defects.

Chemically Modified Messenger RNA: Modified RNA Application for Treatment of Achilles Tendon Defects.

Journal: Tissue engineering. Part A

Published: April 21, 2018

Showing 1-12 of 29

Last Updated: 09/26/2026